Thrombolytic therapy and equivalence trials

J Am Coll Cardiol. 1998 Mar 1;31(3):494-6. doi: 10.1016/s0735-1097(97)00551-2.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Cerebrovascular Disorders / etiology
  • Cerebrovascular Disorders / prevention & control*
  • Fibrinolytic Agents / pharmacology*
  • Humans
  • Myocardial Infarction / complications
  • Myocardial Infarction / drug therapy*
  • Plasminogen Activators / pharmacology*
  • Randomized Controlled Trials as Topic
  • Recombinant Proteins / pharmacology
  • Thrombolytic Therapy*
  • Tissue Plasminogen Activator / pharmacology
  • Urokinase-Type Plasminogen Activator / pharmacology

Substances

  • Fibrinolytic Agents
  • Recombinant Proteins
  • Plasminogen Activators
  • Tissue Plasminogen Activator
  • Urokinase-Type Plasminogen Activator
  • saruplase